"Syngenta, which is set to be acquired by Chinese state-owned ChemChina, said atrazine is safe and that the EPA report 'contains numerous data and methodological errors and needs to be corrected.' If the EPA's report is finalized as written, it could cause label restrictions so severe that they would 'effectively ban the product from most uses,' the Iowa Corn Growers Association said."
Curious Conflict of Interest
Like Monsanto, Syngenta produces patented genetically engineered (GE) seeds, designed to tolerate the pesticides they sell. This is a clear conflict of interest, as their seed business is little more than a means to sell more pesticides.
Another particularly curious conflict of interest raised by Hayes relates to the fact that, up until the year 2000, Syngenta not only produced atrazine, which induces aromatase that causes overproduction of estrogen — an effect that could raise your risk of breast cancer — but the company also produced another chemical, letrozol, which has the converse effect.
It's an aromatase inhibitor that blocks estrogen production, and letrozol was, and still is, a commonly used as treatment for breast cancer.
"[T]he company was simultaneously, in 2000, making a chemical that induced estrogen and promoted breast cancer, and making a chemical that blocked estrogen production and was used to treat breast cancer. So there's a clear conflict of interest there."